“Since its commercial launch in the United States, Omnipod 5 has had a remarkable impact on people with diabetes,” said Jim Hollingshead, Insulet President and CEO. “Every day, we hear how this ...
Insulet Corp. PODD recently announced the commercial launch of its Omnipod 5 Automated Insulin Delivery (“AID”) System for individuals aged two years and older with type 1 diabetes (T1D) in the United ...
OAKVILLE, ON, April 7, 2025 /CNW/ - Insulet Corporation (PODD), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced that Omnipod 5 is now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results